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Purpose: To formulate the crude extract of the leaves of Mitracarpus scarber “Zucc” as a syrup.  
Method: The antimicrobial activity of the formulation was assessed using agar plates and 
concentrations of the extract varying between 25mg/ml and 300mg/ml to determine the minimum 
inhibitory concentration at 37oC against bacterial and fungal organisms namely, Escherichia coli, 
Pseudomonas aeruginosa, Staphylococcus aureus, Sarcina lutea, Candida albicans and Klebsiella 
pneumoniae.  
Result: The growth of Escherichia coli, Staphylococcus aureus, Klebsiella pneumoniae and Candida 
albicans was inhibited by the formulation at a minimum inhibitory concentration of 75mg/ml. 
Pseudomonas aeruginosa, and Sarcina lutea resisted all the concentrations of the formulation used. 
The presence of sucrose in the formulation rendered the formulation pleasant to taste. 
Conclusion: The extract from the leaves of Mitracarpus scarber “Zucc” can be formulated into a 
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INTRODUCTION 
 
The yearly Herbal Medicine Trade Fair in Nigeria 
and the increasing publicity and patronage this 
attracts, irrespective of the social, educational or 
religious background of the people are indicative 
of acceptance of herbal medical practice1. The 
setting up of Traditional Medicine Board by 
some State Governments in our country and the 
on-going registration of herbal products by 
National Agency for Food, Drug Administration 
and Control (NAFDAC) are equally indicative of 
recognition by the Government. 
 
Some drugs of plant origin in conventional 
medical practice are not pure compounds but 
direct extracts or plant materials that have been 
suitably prepared and standardized2. Recently 
the World Health Organization (WHO) has 
recommended the use of Arthemisinin 
derivatives derived from Artemisia annua 
(Composite), a Chinese herb, as a first line drug 
in the treatment of malaria3, 4. This is as a result 
of WHO’s recognition that 80% of world 
population use herbal medicine for some aspect 
of Primary Health Care5.  
 
The plant family, Rubiaceae, which parades a 
long list of plants of medicinal importance, has 
Mitracarpus scarber “Zucc” as example6, 7. It is 
claimed that it possesses antimicrobial activities 
when crude extracts from the plant is used7-10. 
Ahonkhai et al11 formulated the crude extracts 
from the leaves as soap solution but it was 
observed that the availability of the antimicrobial 
principle was hindered by the soap. This was 
attributed to uptake of the active principle by the 
soap. This suggests that a new formulation is 
needed. This study, therefore, aims at 
establishing a simple formulation that does not 
hinder the availability of the active principles 
from the product. Considering that this extract is 
ingested in the treatment of sore throat and 
other upper respiratory diseases, URD,12 despite 
its bitter taste, this study also aims at formulating 




MATERIALS AND METHODS    
Laboratory grades of Petroleum ether and 
methanol from British Drug Houses (BDH) 
as well as Granulated Sugar purchased from 
the open market were used. The following 
media, Blood Agar (Oxoid 271), Nutrient 
Agar (Oxoid) and Sabouraud Agar (Oxoid) 
were equally provided for microbial studies.     
 
The plant was collected locally in Benin-City, 
Nigeria, identified and authenticated as 
Mitracarpus scarber “Zucc”, family 
Rubiaceae, by the plant curator of the 
Herbarium, Department of Pharmacognosy, 
Faculty of Pharmacy University of Benin, 
Benin-City, Nigeria, where a voucher 
specimen of the plant is deposited. It was 
sun dried and powdered using Moulinex mill 
after which it was stored in a dry and well-
stoppered bottle.   
 
 The organisms used were clinical isolates of 
Escherichia coli, Pseudomonas aeruginosa, 
Staphylococcus aureus, Klebsiella 
pneumoniae, Candida albicans and Sarcina 
lutea (from the University of Benin Teaching 
Hospital, Benin-City), Escherichia coli 
(NCTC 10418) and Staphylococcus aureus 
(NCTC 6751) typed cultures. 
 
Preparation of the Crude extract 
1.5kg of the powdered plant material in each 
batch was exhaustively extracted by soxhlet 
extraction method using either Petroleum 
ether, (A), or Methanol, (B), or 70%v/v 
Methanol in H2O, (C). The solvent used in 
each batch was recovered under pressure 
until dry extracts were obtained and then 
stored separately in amber colored bottles 
labeled as A, B and C. 
 
Preparation of Syrup and Simple 
solutions 
The B. P. method 13 was adopted to prepare 
simple syrup, which was used as diluent to 
prepare concentrations of the crude 
extracts, (A, B and C) varying between 
25mg/ml and 300mg/ml from stock solution, 
500mg/ml. For Simple solution, distilled 
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water was used as diluent to prepare the 
same concentrations.  
 
Antimicrobial activity of the Extract 
All the extracts were first screened for 
antimicrobial activity by the Well plate method 14. 
Nutrient and Sabouraud agar plates were 
seeded with overnight cultures of the test 
organisms namely Escherichia coli (NCTC 
10418), Staphylococcus aureus (NCTC 6751) 
and clinical isolates of Escherichia coli, 
Pseudomonas aeruginosa, Staphylococcus 
aureus, Klebsiella pneumoniae, Candida 
albicans and Sarcina lutea. Wells, 15mm wide, 
were cut in the agar plates with cork borer and 
1.5mls of the different extracts were pipetted 
and carefully added to the wells. The Nutrient 
agar plates were incubated right side up at 37oC 
for 24 hrs while the Sabouraud agar plate was 
incubated at room temperature for 48 hrs. The 
zones of inhibition were then measured and the 
mean of two replicates recorded. 
 
Minimum Inhibitory Concentration of Extract 
in Syrup 
The minimum inhibitory concentration was 
determined by Agar dilution method 15. A 1gm/ml 
and 500mg/ml dilution of each of the extract 
were made in water. From these stocks, graded 
concentrations of the extracts in syrup were 
made to achieve 25mg/ml, 50mg/ml, 75mg/ml, 
100mg/ml, 200mg/ml and 300mg/ml final 
concentrations in 20mls of both Nutrient and 
Sabouraud agar plates. These plates were 
spotted with 0.1ml overnight cultures of the test 
organisms. The Nutrient agar plates were 
incubated right side up at 37 oC for 24 hours 
while the Sabouraud agar plates were incubated 
at room temperature for 48 hours. The zones of 
inhibition were measured from two replicates 
and the mean recorded. 
 
RESULTS 
In the Table, the antimicrobial activity of the 
water extract (simple solution) of Mitracarpus 
scarber “Zucc” was demonstrated. All the 
samples inhibited the growth of most of the 
organisms. It also shows the sensitivity of the 
syrup samples prepared using the different 
extraction methods. It therefore indicates that 
the method of extraction did not affect the 
sensitivity of the active principles of the extract 
present in the formulation. Also formulating the 
extract as syrup did not alter their sensitivity. 
The minimum inhibitory concentration (MIC) of 
the extract in syrup was also determined. 
Irrespective of the method of extraction of the 
crude extract, all the syrup formulations were 
 
Table 1: Sensitivity of Extract Samples (A, B & C) at 75mg/ml on Test Organisms  
 
#Zone of Inhibition (Mean)  
 





*C. albicans 22mm 22mm 






*E. coli 20mm 20mm 
*K. pneumoniae 23mm 22mm 
*Ps. aeruginosa nil Nil 
*S. aureus 27mm 26mm 
*Sarcina lutea nil Nil 
 
*:Clinical isolates.    
#: Mean zone diameters from two replicates are recorded 
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active at 75mg/ml against all organisms used 
except Pseudomonas aeruginosa and Sarcina 
lutea which grew even at a high concentration of 
300mg/ml. It is equally interesting to note that 
Candida albicans was inhibited at 75mg/ml.    
 
DISCUSSION 
Reports have shown that the extract of 
Mitracarpus scarber “Zucc” has antibacterial and 
antifungal activities8, 11, and 16. This work equally 
has confirmed such findings. Although 
Ahonkhai, et. al 11 stated that application of heat 
in the extraction method may have affected the 
potency of the antifungal principle(s), this work 
has shown that application of heat to the various 
extracts did not affect the activity of the extract 
to both bacterial and fungal organisms in the 
different formulations. Rather the inhibition to 
growth of the organisms by the extracts can be 
attributed to the potency of active principles as 
well as the strain and possibly, weakness in 
strength of organism used. Previous work 11 
demonstrated that the extract had low activity 
over Pseudomonas aeruginosa despite the fact 
that this organism is known to be a very 
recalcitrant gram-negative organism. This work 
equally confirms that. This further confirms that 
heating may not be responsible for the 
insensitivity shown.  
 
Formulating this extract, as Syrup did not hinder 
the diffusion of the active principle(s) in the 
formulation hence the zones of inhibition at 
75mg/ml recorded for both the simple solution 
and the syrup were the same. Sucrose, a 
sweetening agent and main content of syrup, 
has been used to mask the bitter taste of the 
extract and so, a pleasantly tasting oral dosage 
form of the extract was easily formulated. 
Extract of Mitracarpus scarber “Zucc” can, 
therefore, be formulated as simple syrup.    
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